Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations
暂无分享,去创建一个
D. Shibata | N. Merchant | A. Maker | D. Bartlett | A. Crago | E. Levine | K. McGuire | C. Solórzano | M. Hogg | G. Chang | G. Karakousis | Vance Y. Sohn | K. Turaga | A. Yang | Sam-Youl Yoon | E. Mamounas | J. Howe | R. White
[1] S. Libutti,et al. Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change , 2020, Annals of Surgical Oncology.
[2] P. Burra,et al. Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor , 2020, Updates in Surgery.
[3] E. Nagore,et al. Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model. , 2020, Actas Dermo-Sifiliográficas.
[4] G. D'offizi,et al. Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center , 2020, Updates in Surgery.
[5] J. Donington,et al. Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? , 2020, Surgery.